Novo Nordisk to present new semaglutide data on 'food noise', body composition and cardiovascular benefits, as well as pipeline data at the EASD diabetes congress

Novo Nordisk to present new semaglutide data on 'food noise', body composition and cardiovascular benefits, as well as pipeline data at the EASD diabetes congress — alphai